Gateway to China

July 16, 2019

The drug regulatory authority of China – National Medical Product Administration (NMPA, formerly CFDA) has recently implemented a possibility to report Adverse Drug Reactions (ADR) through an XML-file submission. Flex Databases Pharmacovigilance system users are already able to do so.

There are two general ways of reporting to the regulator – manual submissions through the website and automated gateway submissions. To submit files manually, the company has to register on the Center for Drug Evaluation (CDE) website and get a login and password for a personal cabinet through an Applicant Window.

There is the second way – direct submissions to the regulator’s database through the gateway. To establish the connection between two databases the company must exchange the set of settings with the regulator and test it carefully. After the configuration is done, the company can submit XML-files directly to the reporting system, with minimal user effort involved.

Gateway submission method is the one, preferablе by the regulator. It works faster and ensures a higher level of data security and integrity – the human factor is not affecting the file during its processing between two databases. In the case of highly sensitive data, which ADRs are, it’s a major advantage. Gateway method supposes that the sender receives the acknowledgment receipt from the regulator. This receipt may contain information about submission success or reject as well as the listing of errors detected.

Both methods of submission require XML files, compliant to E2B R3, and our system is fully compliant to the format.

Flex Databases had successfully tested both methods. Automated submission is now added as a feature to our Pharmacovigilance system – and our customers are welcome to use it to submit files and check submission statuses. We also provide a possibility to export an XML file from the system for the manual submission through the CDE website.

Blog

November 9, 2026
Open Position: System Analyst 

We are driven by a mission to make a meaningful impact in the Life Sciences industry. We provide flexible e-Clinical software systems for Clinical Research Organizations (CROs) and pharmaceutical companies worldwide.   Key Responsibilities  Requirement Gathering & Documentation:  Collaboration & Communication:  Process Improvement & Mentorship:  Client Engagement:  Typical Tasks:  Formalizing change requests from customer consultations into […]

October 22, 2026
TMF Standard Model V1: A Major Change Is Coming to Clinical Research

CDISC is introducing TMF Standard Model V1, the next evolution of the widely used TMF Reference Model. This is more than a new version – it represents a shift toward standardized, digitally managed clinical trial records. What’s changing? When will it happen? Community review of the draft is scheduled to begin this autumn, with the […]

October 13, 2026
The Holy Triangle of TMF:  Is It Really Enough to Measure TMF Health by Tracking Its Completeness? 

When vendors build tools to evaluate TMF health, they usually focus on three main KPIs: completeness,  timeliness and quality.  These metrics are obviously important, but are they enough?  A real TMF user will go further and ask the next question:  How long did it take the document to move through each of these stages?  The […]

October 8, 2026
Astrum goes live with Flex Databases: phase one complete

We’re proud to share a milestone with our partners at Astrum: the first phase of their Flex Databases implementation is now live.Project management and project time tracking now run in one shared system. Here’s what changes:– Operational teams log their time directly in Flex – no more local tools or Excel-based tracking– Project managers plan […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.